HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 2, Pages e1171447
Publisher
Informa UK Limited
Online
2017-02-07
DOI
10.1080/2162402x.2016.1171447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevation of c-MYC Disrupts HLA Class II–Mediated Immune Recognition of Human B Cell Tumors
- (2015) Jason M. God et al. JOURNAL OF IMMUNOLOGY
- Tapping CD4 T Cells for Cancer Immunotherapy: The Choice of Personalized Genomics
- (2015) Maurizio Zanetti JOURNAL OF IMMUNOLOGY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
- (2015) Giuseppe Sconocchia et al. NEOPLASIA
- Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer
- (2014) Eva-Maria Surmann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- HLA-DRB1andHLA-DQB1methylation changes promote the occurrence and progression of Kazakh ESCC
- (2014) Jian Ming Hu et al. Epigenetics
- Endosomal compartment: Also a dock for MHC class I peptide loading
- (2014) Wenbin Ma et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses
- (2014) M. Y. Gerner et al. JOURNAL OF IMMUNOLOGY
- The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors
- (2014) Barbara Seliger Journal of Immunotoxicology
- High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia
- (2014) Willemijn van den Ancker et al. LEUKEMIA RESEARCH
- Low expression ofHLA-DRA, HLA-DPA1, andHLA-DPB1is associated with poor prognosis in pediatric adrenocortical tumors (ACT)
- (2014) Fabíola A. Leite et al. PEDIATRIC BLOOD & CANCER
- Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma
- (2014) Mahboobeh Safaeian et al. Frontiers in Oncology
- HLA-A, HLA-B, HLA-DRB1 Polymorphisms and Risk of Cervical Squamous Epithelial Cell Carcinoma: A Population Study in China
- (2013) Xue Xiao et al. Asian Pacific Journal of Cancer Prevention
- HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation
- (2013) Elizabeth D Mellins et al. CURRENT OPINION IN IMMUNOLOGY
- Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation
- (2013) Sébastien Wälchli et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
- (2013) Alka Bhatia et al. Expert Review of Clinical Immunology
- Towards a vaccine to prevent cancer in Lynch syndrome patients
- (2013) Magnus von Knebel Doeberitz et al. Familial Cancer
- Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma
- (2013) Kelly A. Cycon et al. IMMUNOLOGY
- Nitric Oxide and KLF4 Protein Epigenetically Modify Class II Transactivator to Repress Major Histocompatibility Complex II Expression duringMycobacterium bovisBacillus Calmette-Guérin Infection
- (2013) Devram Sampat Ghorpade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional MHC Class II Is Upregulated in Neurofibromin-Deficient Schwann Cells
- (2013) David E. Reuss et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome
- (2013) Anders Näsman et al. PLoS One
- Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma
- (2013) Hannah Phipps-Yonas et al. Frontiers in Immunology
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1
- (2012) Gheath Alatrash et al. JOURNAL OF IMMUNOTHERAPY
- The role of classical and non-classical HLA class I antigens in human tumors
- (2012) Juergen Bukur et al. SEMINARS IN CANCER BIOLOGY
- Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma
- (2012) C. F. Skibola et al. TISSUE ANTIGENS
- Targeting HLA class I expression to increase tumor immunogenicity
- (2012) A. B. del Campo et al. TISSUE ANTIGENS
- Epigenetic regulation of CIITA expression in human T-cells
- (2011) Marja C.J.A. van Eggermond et al. BIOCHEMICAL PHARMACOLOGY
- Absence of Class II-Associated Invariant Chain Peptide on Leukemic Blasts of Patients Promotes Activation of Autologous Leukemia-Reactive CD4+ T Cells
- (2011) M. M. van Luijn et al. CANCER RESEARCH
- Association of IFN- Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines
- (2011) A. Respa et al. CLINICAL CANCER RESEARCH
- Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway
- (2011) Stephanie J Win et al. IMMUNOLOGY AND CELL BIOLOGY
- MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
- (2011) P. Hemon et al. JOURNAL OF IMMUNOLOGY
- Type I IFNs Control Antigen Retention and Survival of CD8 + Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming
- (2011) S. Lorenzi et al. JOURNAL OF IMMUNOLOGY
- Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol
- (2011) Faisal F. Y. Radwan et al. LEUKEMIA & LYMPHOMA
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition
- (2011) Michael Campoli et al. Seminars in Immunopathology
- The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions
- (2010) Federico Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Routes to manipulate MHC class II antigen presentation
- (2010) Tineke van den Hoorn et al. CURRENT OPINION IN IMMUNOLOGY
- Naive tumor-specific CD4+T cells differentiated in vivo eradicate established melanoma
- (2010) Ying Xie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis
- (2010) Marilyn S. Pollack et al. TISSUE ANTIGENS
- Cross-presentation of tumor associated antigens through tumor-derived autophagosomes
- (2009) Yuhuan Li et al. Autophagy
- Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses
- (2009) M. M. van Luijn et al. HAEMATOLOGICA
- MHC class II regulation by epigenetic agents and microRNAs
- (2009) Thomas B. Tomasi et al. IMMUNOLOGIC RESEARCH
- HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers
- (2009) Michael D. Walsh et al. INTERNATIONAL JOURNAL OF CANCER
- The Transcription Factor RFX Protects MHC Class II Genes against Epigenetic Silencing by DNA Methylation
- (2009) Q. Seguin-Estevez et al. JOURNAL OF IMMUNOLOGY
- Maturation Pathways of Dendritic Cells Determine TAP1 and TAP2 Levels and Cross-presenting Function
- (2009) Andrés López-Albaitero et al. JOURNAL OF IMMUNOTHERAPY
- Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma
- (2009) Duncan L. Norton et al. Journal of Oncology
- Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis
- (2008) Philipp Ströbel et al. Annals of the New York Academy of Sciences
- CIITA versus IFN-γ induced MHC class II expression in head and neck cancer cells
- (2008) Markus Meissner et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Loss of interferon-γ inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation
- (2008) M. Meissner et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes
- (2008) Jacques Thibodeau et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling
- (2008) Suhu Liu et al. Pigment Cell & Melanoma Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now